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Abstract Understanding the role of ionic currents in shaping
the cardiac action potential (AP) has great importance as
channel malfunctions can lead to sudden cardiac death by
inducing arrhythmias. Therefore, researchers frequently use
inhibitors to selectively block a certain ion channel like 4,4′-
diisothiocyanostilbene-2,2′-disulfonic acid (DIDS) and 9-
anthracene carboxylic acid (9-AC) for calcium-activated chlo-
ride current (ICl(Ca)). This study aims to explore which blocker
is preferable to study ICl(Ca). Whole-cell voltage-clamp tech-
nique was used to record ICa,L, IKs, IKr and IK1, while action
potentials were measured using sharp microelectrodes. DIDS-
(0.2 mM) and 9-AC-sensitive (0.5 mM) currents were identi-
cal in voltage-clamp conditions, regardless of intracellular
Ca2+ buffering. DIDS-sensitive current amplitude was larger
with the increase of stimulation rate and correlated well with
the rate-induced increase of calcium transients. Both drugs
increased action potential duration (APD) to the same extent,
but the elevation of the plateau potential was more pro-
nounced with 9-AC at fast stimulation rates. On the contrary,
9-AC did not influence either the AP amplitude or the maxi-
mal rate of depolarization (Vmax), but DIDS caused marked
reduction of Vmax. Both inhibitors reduced the magnitude of
phase-1, but, at slow stimulation rates, this effect of DIDS was
larger. All of these actions on APs were reversible upon
washout of the drugs. Increasing concentrations of 9-AC
between 0.1 and 0.5 mM in a cumulative manner gradually
reduced phase-1 and increased APD. 9-AC at 1 mM had no
additional actions upon perfusion after 0.5 mM. The half-
effective concentration of 9-AC was approximately 160 μM
with a Hill coefficient of 2. The amplitudes of ICa,L, IKs, IKr and
IK1 were not changed by 0.5 mM 9-AC. These results suggest
that DIDS is equally useful to study ICl(Ca) during voltage-
clamp but 9-AC is superior in AP measurements for studying
the physiological role of ICl(Ca) due to the lack of sodium
channel inhibition. 9-AC has also no action on other ion
currents (ICa,L, IKr, IKs, IK1); however, ICa,L tracings can be
contaminated with ICl(Ca) when measured in voltage-clamp
condition.
Keywords Calcium-activated chloride current . Canine
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Introduction
Sudden cardiac death as a result of cardiac arrhythmias is a
major cause of death in western civilizations (Fishman et al.
2010). These arrhythmias are often due to malfunctions of
cardiac ion channels (Schmitt et al. 2014). Therefore, under-
standing the role of ionic currents in shaping the cardiac action
potential (AP) has great importance. This could be achieved
by several approaches. One is to use expression systems to
evaluate the biophysical properties of the current. However,
the lack of other potentially important regulatory subunits or
intracellular pathways could be a real disadvantage. Another
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possibility is to reduce the expression of the channel protein in
cell culturing which is a rather difficult process in
cardiomyocytes (Parameswaran et al. 2013). Carefully
planned voltage-protocols together with the suppression of
other currents could be used in native cardiac cells to isolate
the examined current. These artificial conditions are some-
times very far from physiological ones; moreover, the behav-
ior of various currents under an actual action potential can be
drastically different from that recorded with conventional
voltage-clamp (Fülöp et al. 2004). An ideal situation is to
block the investigated channel with a selective inhibitor and
measure the inhibitor-sensitive current either with convention-
al voltage-clamp or action potential voltage-clamp
(Szentandrássy et al. 2011). This solution works very well
only in those rare cases where a truly selective blocker is
available.
Much information is already available about the contribu-
tion of various cationic currents to the cardiac AP, but anionic
currents are much less well characterised (Duan 2009). One of
these anionic currents is the calcium-activated chloride current
(ICl(Ca)) (Eggermont 2004). Regardless of the handful inhibi-
tors used to inhibit this current, a large problem is the missing
identity of the protein responsible for the generation of ICl(Ca).
The most likely candidate is the relatively newly identified
TMEM16 protein (Yang et al. 2008; Forrest et al. 2012);
however, the results are not absolutely conclusive yet. The
discovery of TMEM16 also known as Anoctamin1, and the
possibility that it is the ion channel responsible for ICl(Ca)
recently boosted the research in this field in smooth muscle
(Dam et al. 2014), neuronal, and other tissues (Pedemonte and
Galietta 2014), highlighting the importance of ICl(Ca) in vari-
ous physiological functions.
Traditional anion transporter inhibitors, such as 4,4′-
diisothiocyanostilbene-2,2′-disulfonic acid (DIDS) and 9-
anthracene carboxylic acid (9-AC) are still used to determine
calcium-activated chloride current in different cell types, in-
cluding cardiomyocytes. DIDS (0.1–2 mM) is applied more
frequently for this purpose (Zygmunt 1994; Kawano et al.
1995; Verkerk et al. 2002; Hirayama et al. 2002; Li et al. 2003;
Guo et al. 2008) than 9-AC (0.5–1mM) (Levesque et al. 1993;
Fülöp et al. 2003). Many other compounds were used to
inhibit chloride currents including another stilbene derivative
4-acetamido-4′-isothiocyanostilbene-2,2′-disulfonic acid
(SITS, 1–2 mM) (Zheng et al. 2013; Guo et al. 2008;
Zygmunt and Gibbons 1992), diphenylamine-2-carboxylate
(DPC, 0.5–1 mM) (Walsh and Wang 1996), 5-nitro-2-(3-
phenylpropyl-amino) benzoic acid (NPPB) (Zheng et al.
2013) and also the widely applied niflumic acid (NFA, 30–
200μM) (Xu et al. 2002; Song et al. 2009; Forrest et al. 2012),
just to list a few. These compounds should usually be used in a
quite high concentration to achieve inhibition of the chloride
channels. Moreover, they interact with ion channels found in
the surface of the ventricular myocytes or possess other
unwanted actions, thus their use to determine the physiolog-
ical role of calcium-activated chloride current is limited. For
instance, NFA (100 μM) as well as NPPB (50 μM) also block
the L-type calcium current (ICa,L) by about 50% in isolated rat
ventricular myocytes and reduce calcium transients and cell
shortening (Zhou et al. 2002). NFA (10 μM) also reduced
calcium current in rat uterine cells (Jones et al. 2004).
Regarding the pronounced calcium-dependent feature of
ICl(Ca), it is easy to imagine the magnitude of error introduced
by blocking such a huge fraction of ICa,L by NFA or NPPB.
Moreover, the upstroke of the AP was reduced in a dose-
dependent manner with IC50 values of approximately 70 and
12 μM by NFA and NPPB, respectively (Zhou et al. 2005).
Both blockers reduced sodium current (INa) and induced a
leftward shift in its steady-state inactivation (Zhou et al.
2005). NFA induced an outward current at 0 mV in rat ven-
tricular myocytes in a tyrosine kinase signaling pathway-
mediated manner (Zhou et al. 2007). Another study described
a great reduction of the current flowing through Kv4.3 and
Kv4.2 potassium channels by 100 μM NFA as well as the
alteration of steady-state inactivation (Wang et al. 1997).
Interestingly, the same study reported differential actions of
SITS (2 mM) on the kinetic behavior as it markedly reduced
the recovery from inactivation without altering the steady-
state inactivation curve (Wang et al. 1997). DPC (0.5–
1 mM) also proved to be non-selective as it reduced
forskolin-stimulated ICa,L measured in guinea pig ventricular
myocytes and in mouse atrial myocytes (Walsh and Wang
1996).
Due to the previously described lack of specificity of
commonly applied chloride channel inhibitors, the aim of
the present study was to explore whether DIDS or 9-AC is
preferable to study ICl(Ca) in native left ventricular
cardiomyocytes of the dog. Whole-cell voltage-clamp tech-
nique was used to record ICa,L, IKs, IKr and IK1, while action
potentials were measured using sharp microelectrodes. Our
results suggest that DIDS is equally useful to study ICl(Ca)
during voltage-clamp, but 9-AC is superior in AP measure-
ments for studying the physiological role of ICl(Ca) due to the
lack of INa inhibition.
Materials and methods
Cell isolation
Experiments were carried out on canine left ventricular
myocytes according to a protocol approved by the local ethical
committee and conform to the principles outlined in the
Declaration of Helsinki. Adult beagle dogs of both sexes were
anesthetised by the intramuscular application of the mixture of
10 mg/kg ketamine hydrochloride (Calypsol, Richter Gedeon,
Budapest, Hungary) and 1 mg/kg xylazine hydrochloride
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(Sedaxylan, Eurovet Animal Health BV, Bladel, The
Netherlands). After the establishment of complete narcosis,
the chest was opened, and hearts were quickly removed
followed by washing with Tyrode solution (composition in
mM, NaCl, 144; KCl, 5.6; CaCl2, 2.5; MgCl2, 1.2;
4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid
(HEPES), 5; and dextrose, 11; at pH=7.4.). The atria were
removed, and then the left anterior descendent coronary artery
(LAD) was cannulated. A wedge-shape region of the left
ventricle containing the region supplied by the LAD was cut
out from the heart. This region was perfused with a nominally
Ca2+ free JMM solution (Minimum Essential Medium Eagle,
Joklik Modification, Sigma-Aldrich Co., St. Louis, MO,
USA) supplemented with the followings: taurine, 2.5 g/L;
NaH2PO4, 200 mg/L; NaHCO3, 1.4 g/L; pyruvic acid,
175 mg/L; allopurinol, 13.5 mg/L; D-ribose, 750 mg/L
and having pH of 6.8. After 5 min of perfusion to remove
the blood from the tissue, 1 g/L collagenase (Type II.;
Worthington Biochemical Co., Lakewood, NJ, USA), 2 g/L
bovine serum albumin (Fraction V.; Sigma-Aldrich Co., St.
Louis, MO, USA) and 50 μM CaCl2 were added to the
solution. Enzymatic digestion took usually 25–35 min which
was followed by the collection of isolated myocytes. During
the enzymatic digestion, the solutions were kept at 37 °C and
gassed with a mixture of 95 % O2 and 5 % CO2. The tissue
was cut with a scalpel, and the middle portion of the free
ventricular wall containing mainly mid-myocardial cells was
cut into pieces, sedimented, and filtered several times to
remove big chunks. During this procedure, the calcium level
of the solution was gradually raised to the final 2.5 mM.
Cells were placed into MEM solution (Sigma-Aldrich Co.,
St. Louis, MO, USA) supplemented with the following:
taurine, 2.5 g/L; NaH2PO4, 200 mg/L; NaHCO3, 2 g/L;
pyruvic acid, 175 mg/L; allopurinol, 13.5 mg/L; D-ribose,
750 mg/L having pH of 7.3 and stored at 15 °C until
use but maximum 2 days. The percentage of living cells
having clear cytoplasm and sharp edges showing clear
striations were usually 30–60 %, and only these were used for
electrophysiological recordings.
Electrophysiology
Cells were placed in a plexiglass chamber with a volume of
approximately 1 mL and perfused with a gravity driven sys-
tem at a speed of 2 mL/min. All experiments were done at
37 °C and pH=7.4 in Tyrode solution (composition in milli-
molars, NaCl, 144; KCl, 5.6; CaCl2, 2.5; MgCl2, 1.2; HEPES,
5; and dextrose, 11). The cells were visualised by an inverted
microscope (Eclipse TE2000-U, Nikon, Japan) placed in a
Faraday cage on an anti-vibration table. Electrical signals
were recorded with intracellular amplifiers (MultiClamp
700A and 700B or AxoClamp 2B, Molecular Devices,
Sunnyvale, CA, USA) after analogue–digital conversion
(Digidata 1440A or 1332, Molecular Devices, Sunnyvale,
CA, USA) and recorded with pClamp 10 or 9 softwares
(Molecular Devices, Sunnyvale, CA, USA).
Action potential measurements
APs were recorded in current-clamp mode with borosil-
icate microelectrodes filled with 3 M KCl having a tip
resistance of 20–50 MOhm. Stimulation occurred in
steady-state conditions at variable cycle length elicited
by 1-2-ms-long current pulses having sizes of 120–
130 % of threshold produced by an electronic stimulator
(DS-R3; Főnixcomp Ltd, Hungary). Upon the analysis
of APs, the following parameters were determined:
APD90 value (duration of the AP from the peak to
90 % of repolarization), phase-1 magnitude (voltage
difference between the AP peak and the minimal volt-
age value preceding the dome of the AP), Vmax (the
maximal rate of depolarization) and plateau potential
(the value of the membrane potential at the point cor-
responding to the half duration of APD90).
Voltage-clamp
Ion currents were measured in whole-cell configuration of the
patch-clamp technique (Hamill et al. 1981) and evoked by the
stimulation of square voltage pulses. Upon determination of
chloride channel blocker-sensitive currents, the signals evoked
by voltage pulses were measured in Tyrode solution first
then the measurement was repeated in the presence of the
blocker. The blocker-sensitive currents were calculated
by deducing the current traces measured in the presence
of the blocker from those in the absence of the blocker
(control). The internal solution for these measurements
was the following: (in millimolars) K-aspartate, 110;
KCl, 45; MgCl2, 1; HEPES, 5; and K-ATP, 3, pH=
7.2. In some experiments, indicated on the figures and
text, 10 mM BAPTA was used in the pipette, and the
concentration of K-aspartate was reduced by 10 mM.
For measuring K+ currents, the internal solutions were
made of (in millimolars) K-aspartate, 100; KCl, 45;
MgCl2, 1; HEPES, 5; ethylene glycol tetraacetic acid
(EGTA), 10; and K-ATP, 3, pH=7.2. In case of L-type
Ca2+ current (ICa,L) measurement, the internal solution
contained (in millimolars) KCl, 110; KOH, 40; HEPES,
10; EGTA, 10; tetraethylammonium chloride (TEACl),
20; K-ATP, 3, pH=7.2.
Every chemical was purchased from Sigma-Aldrich
Co., St. Louis, MO, USA. Voltage protocols and further
information will be given at the appropriate section on
“Results”. Current signals were normalised to cell ca-
pacitance measured with 15-ms-long hyperpolarizing
pulses from 0 to −10 mV.
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The osmolarity of all applied solution was carefully adjust-
ed to 295±3 mOsm with a vapor pressure osmometer (Vapro
5520, Wescor Inc., Logan, UT, USA).
Intracellular calcium measurements
Changes in intracellular free Ca2+ concentration were assessed
by epifluorescence technique using the ratiometric dye, Fura-
2-AM. Myocytes were loaded in Tyrode solution with the
membrane-permeant form of 3 μM Fura-2 in the presence of
Pluronic F-127 for 10 min at room temperature. A period of at
least 30 min was allowed for de-esterification of the dye at
room temperature, and then cells were stored at 15 °C until
experiments done within 24 h.
Loaded cells were placed in a 1-ml-volume superfusion
chamber on the stage of an inverted microscope (Eclipse
TE2000-U, Nikon, Japan) and viewed using a ×40 oil immer-
sion objective (CFI S-Fluor ×40 oil, Nikon). During experi-
ments, the bath temperature was set to 37 °C by a temperature
controller (Cell MicroControls, Norfolk, VA, USA).
Cells were field-stimulated through a pair of platinum
wires. Rectangular pulses, having durations of 1–2 ms
and amplitudes of 120–130 % of threshold, were gen-
erated by an electronic stimulator (DS-R3; Főnixcomp
Ltd, Hungary) and delivered at a steady-state frequency
of 0.2–3.33 Hz.
Cells were excited with 340 and 380 nm light from a xenon
arc lamp (Ushio Deutschland GmbH, Steinhöring, Germany).
Excitatory wavelengths were altered by a dual-wavelength
excitation monochromator and an online connected micro-
computer (DeltaScan, Photon Technology International,
New Brunswick, NJ, USA). Fluorescence emission was mon-
itored at 510 nm using a R1527P photomultiplier tube
(Hamamatsu Photonics Deutschland GmbH., Herrsching am
Ammersee, Germany) at an acquisition rate of 500 Hz.
Changes in intracellular free Ca2+ levels were approximated
by the ratio of the fluorescence intensity obtained at 340 and
380 nm excitation after correction for nonspecific background
fluorescence and recorded using FeliX32 Software and
BryteBox Interface (Photon Technology International, New
Brunswick, NJ, USA). Ten consecutive calcium transients
were averaged and analysed offline. The measured parameters
were the baseline and peak fluorescence values, as well as the
amplitude of the transient, calculated as a difference between
the previous two values.
Statistical evaluation
Paired or unpaired Student’s t test followed by one-way
ANOVA was used where appropriate to determine sta-
tistical significance. Differences were considered to be
significant when p<0.05 and were marked with asterisks
on figures.
Results
Calcium-activated chloride current measured as either DIDS-
or 9-AC-sensitive current is identical during conventional
voltage-clamp recording
Conventional voltage-clamp technique was applied first to
investigate ICl(Ca) in canine left ventricular cardiomyocytes.
The current was measured with the application of the two
typically and often used inhibitors: 0.2 mM DIDS or
0.5 mM 9-AC. Cells were clamped to −40 mV as the
holding potential, and the current was activated by 200-
ms-long voltage steps applied between −100 and
+100 mV with 20 mV increments in every 5 s. DIDS-
or 9-AC-sensitive current was determined by deducting the
current traces measured in the presence of the inhibitor
from those recorded in the absence of them and normal-
ised to cell capacitance. DIDS-sensitive current traces
showed rapid activation and reached their peak values
within approximately 10 ms (Fig. 1a) which was also
the case for 9-AC-sensitive currents (Fig. 1b).
Interestingly, not only the activation, but the decay of
the current was also fairly rapid. The current decreased
to near zero 100 ms after the onset of the depolarizing
pulse (Fig. 1a–b). Blocker-sensitive current amplitudes
were determined as the difference between the peak values
(measured between 5–20 ms) and the pedestal values
(measured at the end of the voltage pulse). Currents
activated at potentials higher than −40 mV, and its cur-
rent–voltage relationship had a bell-shaped curve with a
peak value at +60 mV (Fig. 1c). In these experiments, the
pipette solution did not contain EGTA or BAPTA (“with-
out Ca2+ buffering” condition, Fig. 1c) and the current–
voltage relationships in case of the two tested drugs were
practically identical. To test the calcium sensitivity of
ICl(Ca), experiments were repeated with the application
of both inhibitors in a condition when intracellular Ca2+
concentration ([Ca2+]i) was buffered with the application
of 10 mM BAPTA in the patch-pipette (“with Ca2+
buffering” condition, Fig. 1d). DIDS- as well as 9-AC-
sensitive currents were again identical and practically
zero at every potential (Fig. 1d). To further prove the
calcium-dependent nature of ICl(Ca), DIDS-sensitive cur-
rents were measured with a 200-ms-long voltage step
elicited from −40 mV as the holding potential to
+60 mV. This stimulation was applied at various rates
between 0.2 and 2 Hz. The increase in the stimulation
rate resulted in the increase of the amplitude of ICl(Ca)
(Fig. 1g). Intracellular calcium transients evoked by
field stimulation also showed a rate-dependent behavior.
All three studied parameters (peak, baseline and ampli-
tude) increased upon the increase in the rate of stimu-
lation (Fig. 1e–f). A good linear correlation was found
Naunyn-Schmiedeberg's Arch Pharmacol
between the amplitude of ICl(Ca) and all studied param-
eters of the calcium transients. For instance, when
values of ICl(Ca) amplitude and peak values of calcium
transients, all normalised to respective values measured
at 1 Hz were fitted the value of r2 was 0.996 (Fig. 1h).
Comparison of the effects of DIDS and 9-AC on the action
potential measured with sharp microelectrode
Current-clamp studies were conducted in canine left ventric-
ular cardiomyocytes where the actions on various parameters
of the AP were determined. During these measurements, the
conditions are somewhat similar to those in “without Ca2+
buffering” condition as there is no dialysis of the cell in sharp
microelectrode recordings. APs were recorded at five different
steady-state cycle lengths (starting with the longest and ap-
plying progressively shorter ones) in control condition. This
was followed by the application of either 0.2 mM DIDS or
0.5 mM 9-AC. After the changes induced by the inhibitors
reached a steady level (usually within 7–8 min), the AP
measurements at the different cycle lengths were repeated.
As the last step, the washout of the inhibitors was performed
to test the reversibility of the changes. The AP parameters of
the control condition at 1 Hz were the following: −80.7±
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0.7 mV for resting membrane potential, 233.0±9.1 ms for
APD90, 22.3±2.1 mV for phase-1 magnitude, 250.8±54.1 V/s
for Vmax and 4.5±2.0 mV for plateau potential (n=21). The
contours of the APs were modified by the two inhibitors in a
similar fashion except the upstroke of the AP (Fig. 2a–b).
Action potential duration was determined at the level of 90 %
repolarization (APD90) and increased by both inhibitors in a
similar, reverse rate-dependent manner (Fig. 2c). Phase-1
magnitude was determined as the difference between the
membrane potential values of the peak and the deepest point
of the notch. The reduction in phase-1 was observed by both
inhibitors, but the cycle length dependence of the magnitude
of this reduction was different (Fig. 2d). There was a greater
reduction at long cycle length with 9-ACwhereas the opposite
was the case for DIDS, leading to a significantly greater
reduction at 2- and 5-s-long cycle lengths compared with that
seen with 9-AC. In case of DIDS, this change was similar in
every studied cycle length and smaller compared with that
seen in 9-AC at cycle lengths of 0.3 and 0.5 s. Both the
amplitude of the AP (not shown) and the value of Vmax
(Fig. 2e) were reduced by only DIDS whereas 9-AC did not
influence these parameters. The plateau potential, measured at
the 50 % of APD90, was dependent on the rate of stimulation
only if 9-AC was applied and the increase in the plateau
potential was greater at short cycle lengths (Fig. 2f). The
values of the resting membrane potential were not altered by
either DIDS or 9-AC.
Dose-dependent effects of 9-AC on the AP
Current-clamp studies were continued to determine whether
the previously applied dose of 9-AC was sufficient to achieve
maximal inhibition of ICl(Ca). In these experiments, the stim-
ulation cycle length was 1 s, and increasing concentrations of
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stimulation. Symbols and bars
represent mean±SEM values;
asterisks denote significant
changes from control (p<0.05);
plus signs show significant
difference between the actions of
the two inhibitors, and n indicates
the number of experiments
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9-AC were applied in a cumulative manner in the range of
0.05–1 mM. As mentioned with the previous experiments, it
took 7–8 min to reach steady-state actions of the inhibitor;
therefore, at least 7 min of perfusion period was used for each
dose. The previously seen reduction of phase-1 and increases
in plateau potential and APD90 values evoked by 9-AC de-
veloped gradually by increasing concentrations of the inhibi-
tor (Fig. 3a). The smallest dose evoking significant action on
both APD90 and phase-1 values was 0.3 mM (Fig. 3b–c). The
application of 1 mM 9-AC did not increase the changes of AP
parameters evoked by the previous dose of 0.5 mM 9-AC any
further (Fig. 3b–c). The 9-AC-induced changes of phase-1
magnitude and APD90 values were converted to give a range
of 0–100 % in a way that the maximal change induced by the
highest applied dose of 9-ACwas considered as 100%. Those
converted values, obtained in each of ten measurements, were
averaged and plotted on Fig. 3d–e as a function of 9-AC
concentration. These points were fitted to Hill equation (y=
1/(1+(EC50/x)^n) where EC50 is the half-effective 9-AC con-
centration and n is the Hill coefficient. EC50 values were
167.2±12.4 and 158.2±8.2 μM whereas Hill coefficients
were 2.04±0.22 and 1.81±0.13 in cases of 9-AC-induced
changes of phase-1 magnitude and APD90, respectively.
Effects of 9-AC on various cardiac cationic currents measured
by conventional voltage-clamp
The previous current-clamp studies showed the similarities as
well as the difference in the actions of DIDS and 9-AC on the
AP of canine left ventricular myocytes. The reduction of AP
amplitude and Vmax in case of DIDS suggested the inhibition
of sodium channels by that inhibitor. This action was not seen
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Fig. 3 Cumulative dose-
dependent effect of 9-AC on
ventricular AP. a Representative
APs measured by sharp
microelectrodes in control, in the
presence of various
concentrations of 9-AC followed
by washout of 9-AC. The circled
insert shows the phase-1 of these
APs enlarged. b, c Values of
phase-1 magnitude (panel b) and
APD90 (panel c) in control, in the
presence of increasing
concentrations of 9-AC followed
by washout of the blocker. d, e
Cumulative dose-dependent
9-AC-induced changes of phase-1
magnitude (panel d) and APD90
(panel e) normalised to the
maximal changes. Points were
fitted to Hill equation resulting in
the solid lines. Parameters on the
figures show the values±SEM of
half-effective concentration
(EC50) and Hill coefficients.
Columns or symbols and error
bars are mean±SEM values; n
indicates the number of
experiments
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with the application of 9-AC even in the highest applied dose
(1 mM). To further test the possible non-selective actions of
9-AC, the major cationic currents were measured in control
conditions and after the application of 10 min of 0.5 mM 9-
AC (Fig. 4).
Effects of 9-AC on the L-type calcium current (ICa,L)
ICa,L was activated by 400-ms-long depolarizations to +5 mV,
arising from the holding potential of −40 mV at a rate of
0.2 Hz. In these experiments, Tyrode solution was
supplemented with 3 mM 4-aminopyridine (to block the tran-
sient outward potassium current, Ito1), 1 μME-4031 (selective
IKr inhibitor) and 1 μMHMR-1556 (selective IKs inhibitor) in
order to block potassium currents. The amplitude of ICa,L was
unaltered by 9-AC. In the six studied cells, ICa,L density was
−5.34±0.44 A/F in control condition and −5.27±0.44 A/F in
the presence of 9-AC (Fig. 4b). It must be highlighted, how-
ever, that the inactivation of ICa,L largely overlaps with ICl(Ca)
as the decay of the current was much faster in control condi-
tion compared with that seen in the presence of 9-AC. Indeed,
when calculating the 9-AC-sensitive current from the two
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Fig. 4 Effect of 0.5 mM 9-AC on
major ventricular ion currents.
Representative recording
showing ICa,L current (panel a),
IKr tail current (panel c), IKs tail
current (panel e) and IK1 current
(panel g). Current amplitudes in
control and in the presence of
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traces (see insert of Fig. 4a), its time course and size greatly
resemble those seen on Fig. 1b.
Effects of 9-AC on the rapid component of delayed rectifier
potassium current (IKr)
IKr was activated by 1-s-long depolarizing pulses to +50 mV
arising from the holding potential of −40 mV. This voltage
protocol was repeated once in every 20 s. IKr was assessed as
tail current amplitudes recorded following repolarization to
the holding potential. ICa,L and the slow component of delayed
rectifier potassium current (IKs) were suppressed by 1 μM
nisoldipine and 1 μM HMR-1556, respectively. The am-
plitude of the IKr tail currents was unaffected by 9-AC
(Fig. 4c–d). In the four studied myocytes, 0.73±0.05 A/F
was the density of IKr tail current in control whereas it
was 0.72±0.05 A/F in the presence of 9-AC (Fig. 4d).
Effects of 9-AC on the slow component of delayed rectifier
potassium current (IKs)
IKs was also evaluated as a tail current and recorded at the
holding potential of −40 mV. The current was activated by 5-
s-long depolarizations to +50 mV, and the bathing medium
contained 1 μM nisoldipine and 1 μM E-4031 in order to
eliminate ICa,L and IKr, respectively. IKs tail currents were
unchanged during 10 min of 9-AC perfusion in the five
myocytes examined, being 1.66±0.03 and 1.61±0.05 A/F in
control and in 9-AC, respectively (Fig. 4e–f).
Effects of 9-AC on inward rectifier potassium current (IK1)
IK1 was recorded with a hyperpolarizing pulse from −80 to
−135mVapplied for 1 s. IK1 current was determined at the end
of the pulse and showed no change in the six studied cells,
being −18.00±1.54 and −18.36±2.16 A/F in control and in
9-AC, respectively (Fig. 4g–h).
Discussion
The major finding of this study is that 9-AC is a better tool to
study the physiological role of ICl(Ca) in AP measurements
compared with DIDS due to the lack of sodium channel
inhibition in case of the former. 9-AC has also no effect on
the other main ion currents (ICa,L, IKr, IKs, IK1) in ventricular
myocytes; however, ICa,L tracings can be contaminated with
ICl(Ca). This can cause problems especially when the decay of
ICa,L is to be fitted by mono- or biexponential functions. The
lack of calcium current inhibition by 9-AC in this study is
actually in contrast to the result ofWalsh andWang (1996), as,
in that study, the same dose of 0.5 mM 9-AC was reported to
cause 60% inhibition of ICa,L stimulated by 1–2μM forskolin.
A potential explanation of this discrepancy can be the different
preparation as they used isolated guinea pig ventricular cells in
contrast to the canine myocytes in the present study. Also,
forskolin stimulation was not applied in our study. Another
report regarding the inhibition of voltage-dependent calcium
channels evoked by 9-AC is the review of Kocic (2005), but
unfortunately no reference was mentioned there. Other stud-
ies, however, found no inhibition of calcium current with
1 mM 9-AC in sheep (Cotton et al. 1997) and rat smooth
muscle (Baron et al. 1991) as well as with 0.1 mM 9-AC in rat
uterine muscle (Jones et al. 2004) in agreement with the
present study.
9-AC just as DIDS reduced the volume-regulated chloride
current in guinea pig cardiac myocytes, but none of the two
inhibitors altered the isoprenaline-activated chloride currents
(Vandenberg et al. 1994). In this study, the volume-regulated
chloride current was unlikely to be present as the osmolarity of
the perfusion solution was carefully adjusted. Contrary to the
results of Vandenberg et al. (1994), 9-AC reduced cAMP-
dependent chloride channels in guinea pig ventricular
myocytes (Levesque et al. 1993; Harvey et al. 1990). It must
be noted, however, that protein kinase A-activated chlo-
ride current (ICl,PKA) is not present either in canine
(Sorota et al. 1991) or human heart (Oz and Sorota
1995).
DIDS is also used very often to study ICl(Ca). The volume-
regulated chloride current was blocked by 0.1 mM DIDS by
60 and 100 % in guinea pig (Vandenberg et al. 1994) and in
canine atrial myocytes (Sorota 1994), respectively. Unlike
9-AC, DIDS (1 mM) did not reduce ICl,PKA in guinea pig
papillary muscles (Shida et al. 1992); indeed, stimulation was
reported in guinea pig ventricular myocytes; however, the
author concluded that this was not a direct action on the ion
channels but due to an activation of beta-adrenergic receptors
(Harvey 1993). DIDS at 10–100 μM enhanced expressed IsK
channels but had no effects on homopolymeric KvLQT1
channel proteins (Busch et al. 1997).
According to the results of the current study, it is likely that
DIDS reduces INa as Vmax was reduced, and that parameter is
an established indicator of fast sodium channel blockade and
can be used as an indirect INa measurement (Strichartz and
Cohen 1978). Not only DIDS but NFA and NPPB had similar
actions on Vmax (Zhou et al. 2005). Moreover, both NFA and
NPPB reduced INa and induced a leftward shift in its steady-
state inactivation as was observed in direct voltage-clamp
experiments (Zhou et al. 2005). Indeed, direct evidence exists
that DIDS inhibits INa of guinea pig ventricular myocytes with
an EC50 of 0.15 mM (Liu et al. 1998). It seems therefore that
the inhibition of the INa can be found in case of DIDS but not
with 9-AC, in agreement with the results of our previous study
(Fülöp et al. 2003) where the reduction of Vmax was not found.
On the other hand, one must emphasise that DIDS is equally
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useful to study ICl(Ca) during voltage-clamp when INa inhibi-
tion is not an issue due to the constant inactivated state of the
channels. This is illustrated in an exceptionally convincing
way in this study as the actions of the two inhibitors on ICl(Ca)
are indistinguishable (Fig. 1). Similar current amplitudes were
recorded in the whole examined voltage range by both drugs.
This indicates that ICl(Ca) have the same magnitude measured
either as 0.2 mM DIDS- or 0.5 mM 9-AC-sensitive current,
suggesting that the blocking potency of the two drugs is prob-
ably the same. According to the study of Kawano et al. (1995),
0.2 mM DIDS evoked a complete inhibition of ICl(Ca) in rabbit
ventricular myocytes, while the reduction of the current by
0.1 mM DIDS was only 70 % in rabbit Purkinje cells (Sipido
et al. 1993). It must be noted, however, that, in the latter study,
theUVillumination used for intracellular calcium concentration
measurements could degrade the inhibitor. Another study per-
formed again on rabbit ventricular myocytes described full
inhibition of ICl(Ca) by 0.1 mM DIDS (Zygmunt and Gibbons
1991). Similarly, in murine ventricular cells, 0.1 mM DIDS
completely abolished the calcium-activated outward cur-
rent (Xu et al. 2002) as well as full reduction was found
in swine ventricular myocytes by 0.15 mM DIDS (Li
et al. 2003). In case of 9-AC, much less information is
available regarding its ICl(Ca) inhibitory action in direct
current measurements. Approximately 90 % reduction
was reported by Szigeti et al. (1998) in rabbit heart by
0.5 mM 9-AC. In rat uterine myocytes, 0.1 mM 9-AC
greatly reduced ICl(Ca) (Jones et al. 2004). In swine atrial
myocytes, 0.2 mM 9-AC as well as 0.2 mM DIDS highly
reduced ICl(Ca), causing practically a complete inhibition (Li
et al. 2004).
DIDS-sensitive current had a characteristic bell-shaped cur-
rent-voltage relationship (Fig. 1) in agreement with previous
studies (Zygmunt and Gibbons 1992; Verkerk et al. 2002). The
outward rectification of the channel is clearly demonstrated,
and the decrease at high voltages (more positive than +60 mV)
is presumably caused by the limited Ca2+ entry at these poten-
tials (Fig. 1c). Our measurements were performed not only in
the probably more physiological situation, when EGTA or
BAPTAwas not applied in the pipette solution, but also when
[Ca2+]i was strongly buffered (in the presence of 10 mM
BAPTA in the pipette solution), clearly demonstrating the
calcium-activated nature of the ICl(Ca) (Fig. 1d). The calcium-
dependence of ICl(Ca) is clearly shown when DIDS-sensitive
current amplitude increased in good correlation with the peak
value of intracellular calcium concentration upon modification
of stimulation rate (Fig. 1h). Intracellular calcium measure-
ments were carried out only in the absence of chloride channel
inhibitors as both 9-AC and DIDS were reported to have
autofluorescence (Jones et al. 2004; Sipido et al. 1993), respec-
tively. Moreover, the UV illumination used for intracellular
calcium concentration measurements could degrade DIDS
(Sipido et al. 1993). The increase of calcium transients with
high rate of stimulation is similar to what was presented by
Sipido et al. (2000). Moreover, the increase of calcium-
activated chloride current was also demonstrated, even in the
absence of any inhibitor (Sipido et al. 1993). This latter obser-
vation suggests that use-dependent blockade of ICl(Ca) by the
applied inhibitors is unlikely; however, it cannot be ruled out
completely. Unfortunately, according to at least our knowledge,
there are no available data regarding the use-dependent nature
of ICl(Ca) by any inhibitor.
Interestingly, not only the activation, but the decay of ICl(Ca)
was also fairly rapid, as it decreased to near zero within
100 ms after the onset of the depolarizing pulse just as in
two other studies (Zygmunt and Gibbons 1992; Verkerk et al.
2002). This phenomenon is quite opposite compared with that
observed with expressed TMEM16A channels, where a main-
tained component also can be seen (Bradley et al. 2014). This
can be a result of the physiological [Ca2+]i changes and the
remarkable compartmentalization, factors which are much
more pronounced in native cardiac myocytes (Trafford et al.
1998; Zhang et al. 2014).
The previously mentioned compartmentalization, together
with the known difference in rate of calcium buffering of the
two applied buffers (BAPTA is 100 times faster than EGTA,
Pásek et al. 2014), can explain the seeming discrepancy of our
findings: lack of ICl(Ca) in the presence of BAPTA (Fig. 1d)
and the contamination of ICa,L tracings with ICl(Ca) in the
presence of EGTA (Fig. 4a). BAPTA, acting as a fast calcium
buffer, is often used to chelate calcium not only in the bulk
cytoplasm but also in the subsarcolemmal space, where calci-
um levels rise to much higher values (Pásek et al. 2014).
EGTA, on the contrary, is only capable of reducing calcium
levels of the bulk cytoplasm resulting in the cessation of
contractions. At the same time, those events, depending on
the presence of subsarcolemmal calcium including the
calcium-dependent inactivation of L-type calcium current,
calcium fluxes via sodium-calcium exchanger and sarcolem-
mal calcium pump, are hardly affected by EGTA. That is
probably the case for ICl(Ca) in this study, explaining the
presence of ICl(Ca) even when 10 mM EGTA was applied.
Similarly to the present study, BAPTA, but not EGTA
(10 mM each), effectively buffered subsarcolemmal calcium
in murine ventricular cardiomyocytes (Keskanokwong et al.
2011).
Comparing the actions of the two studied inhibitors on
various parameters of the AP, the most important difference
was the presence or absence of Vmax reduction with DIDS or
9-AC, respectively (Fig. 2e). DIDS was not mentioned to
reduce the Vmax parameter in rabbit (Verkerk et al. 2004;
Hirayama et al. 2002) or in canine (Zygmunt et al. 1997),
contrary to the result of the present study. A potential expla-
nation can be the different species or experimental conditions
as in the rabbit study whole-cell patch clamp was done instead
of the more physiological conventional sharp microelectrode
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recording of the present study. The duration of AP did not
always increase by DIDS just as the reduction of phase-1 was
not evident in subepicardial myocytes in the study of Verkerk
et al. (2004) only after the reduction of Ito1 by 4-
aminopyridine. The current study however was done on
mid-myocardial cells expressing a smaller Ito1 compared with
subepicardial ones (Szabó et al. 2005). In the study of
Zygmunt et al. (1997), DIDS did not increase the duration of
AP and had no action on either the phase-1 or Vmax when
whole-cell recording was carried out. It must be noted however
that in the pipette solution 20mMEGTAwas used instead of the
lack of any calcium buffering in the present study. In case of
perforated-patch experiments, again, 0.2 mM DIDS (same dose
used in this study) elevated the plateau potential but reduced the
value of APD90 and barely had any influence on phase-1 in the
study of Zygmunt et al. (1997). A possible explanation for the
difference can be again the different type of cell as subepicardial
cell was presented in which there are stimulation frequencies
where the shortening of the AP was also observed by us (not
shown). Another difference is the steady-state pacing used in
this study and the lack of that in the study of Zygmunt et al.
(1997). The effect of DIDS on the duration of the AP was
similar in rabbit ventricular myocytes (Hirayama et al. 2002)
to what was the case in the present study, namely prolongation
of the AP. On the contrary, no marked action on phase-1 was
shown in that work which could be due to again the whole-cell
patch-clamp recording in that work versus the conventional
sharp microelectrode recording in the present study.
As was demonstrated, the action of the two studied
inhibitors on various AP parameters were largely identical
(except those on Vmax and AP amplitude), although slight
differences in phase-1 and plateau potential changes in-
duced by the two drugs were seen (Fig. 2d, f). A greater
reduction of phase-1 was seen at long cycle lengths (2 and
5 s, Fig. 2d) with 9-AC. The magnitude of phase-1 de-
pends on many ion currents including INa, Ito1, ICl(Ca) and
ICa,L and the precise timing of their activation, inactivation
and reactivation. DIDS was shown earlier to reduce at least
three of these (INa, ICl(Ca) and ICa,L) whereas there is no
evidence that 9-AC reduces any other current apart from
ICl(Ca). Moreover, the rate-dependence of these currents can
complicate the picture as phase-1 magnitude itself shows
reverse rate-dependence having larger values at longer cy-
cle lengths mainly due to two factors working simulta-
neously. First, the slow recovery from inactivation of Ito1,
which decreases the amplitude of Ito1 at increasing heart
rates (Wang et al. 1999), and secondly, ICa,L increases with
the reduction of cycle length in a Ca2+-calmodulin protein
kinase (CaMKII)-dependent regulatory pathway (also called
as Ca2+ current facilitation), resulting in an earlier elevation
of the AP plateau (Bers and Morotti 2014). Thus, the direct
rate-dependent effect of 9-AC on phase-1 magnitude could
be the result of clear-cut inhibition of ICl(Ca), in which
current is increasing at higher stimulatory frequencies as it
probably follows the frequency-dependent properties of the
Ca2+ entry and calcium transients (see earlier in
“Discussion”) while the reverse rate-dependent effect of
DIDS on phase-1 could be attributed to an almost constant
INa blockade, reflecting the general feature of frequency-
dependence of phase-1 magnitude. Therefore, the difference
in rate-dependent inhibition of phase-1 by the two studied
blockers can simply be due to weaker selectivity of DIDS.
The reverse rate-dependency of AP lengthening after the
application of either DIDS or 9-AC shows the intrinsic prop-
erty of APD modulation rather than the frequency-
dependence of the blocked ion current (Bányász et al. 2009).
The effect of DIDS on plateau potential was small but
statistically significant and did not depend on stimulation rate.
On the contrary, 9-AC increased plateau potential in a direct
rate-dependent manner resulting in the smaller effect of DIDS
at short cycle lengths (0.3 and 0.5 s, Fig. 2f). The weaker
selectivity of DIDS can provide again a possible explanation
as the reduction of ICa,L likely causes the reduction of plateau
potential (or more precisely the smaller increase of that)
compared with 9-ACwhich was actually the case at all studied
cycle lengths.
Concentration-dependent effect of 9-AC on ventricular AP
was also studied. Concentrations of 9-AC were ranging from
0.1 to 1 mM to achieve chloride channel inhibition in the
literature (Szigeti et al. 1998; Walsh and Wang 1996). The
reduction in phase-1 magnitude just as the lengthening of AP
was saturated at 0.5 mM of 9-AC as 1 mM 9-AC did not
increase these changes much further (both APD90 and phase-1
magnitude values did not differ significantly in the presence of
0.5 and 1 mM 9-AC, Fig. 3b–c). The half-effective doses,
determined from 9-AC-induced changes of two AP parame-
ters, were very similar to each other (167.2±12.4 and 158.2±
8.2 μM in cases of phase-1 magnitude and APD90, respec-
tively). Moreover, even the values of Hill coefficients were
close being 2.04±0.22 and 1.81±0.13 in cases of phase-1
magnitude and APD90, respectively. It must be noted, how-
ever, that both parameters (phase-1 magnitude and APD90)
depend on not only one ionic current, but also on the
fine-tuned interplay between several ionic currents, includ-
ing Ito1, INa and ICa,L in case of phase-1 magnitude and
even more in APD90. Therefore, this must be kept in
mind when comparing these half-effective doses with data
available in the literature. The half-inhibitory dose of 9-
AC on TMEM16A currents in HEK 293 cells that stably
expressed human TMEM16A was reported to be 58 μM
(Bradley et al. 2014). Calcium-sensitive chloride current
was reduced by 9-AC with a half-inhibitory dose of
80 μM on brown fat cells (Pappone and Lee 1995). The
EC50 of 9-AC was higher in our study comparing to the
other two recently mentioned reports. It is hard to com-
pare these results and find a possible explanation for the
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less potent effect of 9-AC in our case for multiple reasons.
One reason might be, for instance, the totally different
preparation, as canine ventricular myocytes were used in
our study whereas brown fat cells and TMEM16A-
expressing cells were used in the other two. Secondly,
direct ion current measurements were made in the other
studies whereas we calculated half-effective concentrations
based on the actions of 9-AC on the cardiac AP (see
above). It is worth emphasizing that our EC50 values were
almost identical regardless of which AP parameter was
used to determine those. This suggests that both the
lengthening of AP and the reduction of phase-1 magnitude
is likely to be the result of 9-AC-induced ICl(Ca) inhibition.
Comparing the Hill coefficients with values available in
literature is not possible as, according at least to our
knowledge, this is the first report available for such value
in case of 9-AC. Moreover, Hill coefficients are not
mentioned in case of other inhibitors such as DIDS or
any other often used ones. From our results, one can draw
the conclusion that the application of 9-AC in 0.5 mM
dose is suitable to examine ICl(Ca) as that dose completely
inhibits the chloride current (see earlier in “Discussion”)
and its actions on the morphology of the AP are saturated.
In conclusion, there was no difference in the actions of
DIDS and 9-AC on ICl(Ca) examined with standard, rectangu-
lar voltage pulses. DIDS, however, significantly blocks fast
sodium channels; therefore, it is not suitable in AP measure-
ments, when the investigation focuses on the physiological
role of ICl(Ca) in the formation of APs. The difference between
the action of the blockers on AP is becoming even more
pronounced at increasing heart rates, resulting in the fact that
DIDS but not 9-AC fails to demonstrate the frequency-
dependent properties of ICl(Ca). Other major ventricular ion
currents (ICa,L, IKr, IKs, IK1) were not affected by 9-AC in a
dose (0.5 mM) close to that completely blocks chloride chan-
nels. However, in native cells, L-type calcium current tracings
can be contaminated with ICl(Ca) using physiological ion com-
position, resulting in difficulty when inactivation kinetics of
ICa,L is about to be determined in the absence of the ICl(Ca)
blockade.
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